Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'C-ERBB-2 ONCOPROTEIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 152 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jaehne, M; Jakel, KT; Roser, K; Ussmuller, J; Loning, T
      About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study.

      LARYNGO-RHINO-OTOLOGIE
    2. Hatanaka, Y; Hashizume, K; Kamihara, Y; Itoh, H; Tsuda, H; Osamura, RY; Tani, Y
      Quantitative immunohistochemical evaluation of HER2/neu expression with HercepTest(TM) in breast carcinoma by image analysis

      PATHOLOGY INTERNATIONAL
    3. Osman, I; Scher, HI; Drobnjak, M; Verbel, D; Morris, M; Agus, D; Ross, JS; Cordon-Cardo, C
      HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer

      CLINICAL CANCER RESEARCH
    4. Baselga, J; Albanell, J
      Mechanism of action of anti-HER2 monoclonal antibodies

      ANNALS OF ONCOLOGY
    5. Skalova, A; Starek, I; Kucerova, V; Szepe, P; Plank, L
      Salivary duct carcinoma - A highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression

      PATHOLOGY RESEARCH AND PRACTICE
    6. Sakorafas, GH; Blanchard, K; Sarr, MG; Farley, DR
      Paget's disease of the breast

      CANCER TREATMENT REVIEWS
    7. Small, EJ; Bok, R; Reese, DM; Sudilovsky, D; Frohlich, M
      Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer

      SEMINARS IN ONCOLOGY
    8. Yarden, Y
      Biology of HER2 and its importance in breast cancer

      ONCOLOGY
    9. Gibbons, MD; Manne, U; Carroll, WR; Peters, GE; Weiss, HL; Grizzle, WE
      Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands

      LARYNGOSCOPE
    10. Shi, Y; Brands, FH; Chatterjee, S; Feng, AC; Groshen, S; Schewe, J; Lieskovsky, G; Cote, RJ
      HER-2/neu expression in prostate cancer: High level of expression associated with exposure to hormone therapy and androgen independent disease

      JOURNAL OF UROLOGY
    11. Piechocki, MP; Pilon, SA; Wei, WZ
      Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2

      JOURNAL OF IMMUNOLOGY
    12. Khan, AJ; DiGiovanna, MP; Ross, DA; Sasaki, CT; Carter, D; Son, YH; Haffty, BG
      Adenoid cystic carcinoma: A retrospective clinical review

      INTERNATIONAL JOURNAL OF CANCER
    13. Bijker, N; Rutgers, EJT; Duchateau, L; Peterse, JL; Julien, JP; Cataliotti, L
      Breast-conserving therapy for Paget disease of the nipple - A prospective European Organization for Research and Treatment of Cancer Study of 61 patients

      CANCER
    14. Reese, DM; Small, EJ; Magrane, G; Waldman, FM; Chew, K; Sudilovsky, D
      HER2 protein expression and gene amplification in androgen-independent prostate cancer

      AJCP. American journal of clinical pathology
    15. O'Malley, FP; Parkes, R; Latta, E; Tjan, S; Zadro, T; Mueller, R; Arneson, N; Blackstein, M; Andrulis, I
      Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry

      AJCP. American journal of clinical pathology
    16. Ross, JS
      The HER-2/neu gene and protein in breast cancer: Methods of detection and clinical significance

      JOURNAL OF CLINICAL LIGAND ASSAY
    17. Sahin, AA
      Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer

      ADVANCES IN ANATOMIC PATHOLOGY
    18. Porebska, I; Harlozinska, A; Bojarowski, T
      Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2. ERB B3) in colorectal adenocarcinomas and adenomas

      TUMOR BIOLOGY
    19. Walker, RA
      The significance of histological determination of HER-2 status in breast cancer

      BREAST
    20. Molino, A; Pavarana, M; Micciolo, R; Nortilli, R; Pedersini, R; Manno, P; Bozzi, P; Bonetti, F; Piubello, Q; Cetto, GL
      Comparative study of clinical, pathological and biological characteristicsof symptomatic versus asymptomatic breast cancers

      ANNALS OF ONCOLOGY
    21. Sutterlin, MW; Haller, A; Gassel, AM; Peters, K; Caffier, H; Dietl, J
      The correlation of c-erbB-2 oncoprotein and established prognostic factorsin human breast cancer

      ANTICANCER RESEARCH
    22. Martin-Lacave, I; Utrilla, JC
      Expression of a neu/c-erbB-2-like product in neuroendocrine cells of mammals

      HISTOLOGY AND HISTOPATHOLOGY
    23. Wu, JT; Zhang, P; Bentz, JS
      Quantification of HER2 oncoprotein in fine-needle aspirates of the breast

      ANNALS OF CLINICAL AND LABORATORY SCIENCE
    24. Grzanka, A; Skok, Z; Janiak, A; Grzanka, D
      Immunoelectron microscopical identification of the c-erbB-2 oncoprotein inpatients with laryngeal squamous cell carcinoma

      ACTA HISTOCHEMICA
    25. Niewiadomska, H; Mirowski, M; Stempien, M; Blonski, JZ; Czyz, W; Switalska, J; Matyga, E; Hanausek, M; Wierzbicki, R
      Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients

      NEOPLASMA
    26. Zekri, ARN; Bahnassy, AA; Shaarawy, SM; Mansour, OA; Maduar, MA; Khaled, HM; El-Ahmadi, O
      Hepatitis C virus genotyping in relation to neuoncoprotein overexpression and the development of hepatocellular carcinoma

      JOURNAL OF MEDICAL MICROBIOLOGY
    27. Menard, S; Tagliabue, E; Campiglio, M; Pupa, SM
      Role of HER2 gene overexpression in breast carcinoma

      JOURNAL OF CELLULAR PHYSIOLOGY
    28. Visco, V; Bei, R; Moriconi, E; Gianni, W; Kraus, MH; Muraro, R
      ErbB2 immune response in breast cancer patients with soluble receptor ectodomain

      AMERICAN JOURNAL OF PATHOLOGY
    29. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry - A study of interlaboratory agreement

      AJCP. American journal of clinical pathology
    30. Mai, KT; Yazdi, HM; Perkins, DG
      Mammary Paget's disease: Evidence of diverse origin of the disease with a subgroup of Paget's disease developing from the superficial portion of lactiferous duct and a discontinuous pattern of tumor spread

      PATHOLOGY INTERNATIONAL
    31. Wan, XS; Meyskens, FL; Armstrong, WB; Taylor, TH; Kennedy, AR
      Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    32. Kersemaekers, AMF; van de Vijver, MJ; Kenter, GG; Fleuren, GJ
      Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix

      GENES CHROMOSOMES & CANCER
    33. Ross, JS; Fletcher, JA
      The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy

      SEMINARS IN CANCER BIOLOGY
    34. Hanna, W; Kahn, HJ; Trudeau, M
      Evaluation of HER-2/neu (erbB-2) status in breast cancer: From bench to bedside

      MODERN PATHOLOGY
    35. Querzoli, P; Albonico, G; Ferretti, S; Rinaldi, R; Magri, E; Nenci, I
      Quantitative immunoprofiles of breast cancer performed by image analysis

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    36. Jacobs, TW; Gown, AM; Yaziji, H; Barnes, MJ; Schnitt, SJ
      Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    37. Nakopoulou, LL; Tsitsimelis, D; Lazaris, AC; Tzonou, A; Gakiopoulou, H; Dicoglou, CC; Davaris, PS
      Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: Correlation with clinicopathologic parameters

      CANCER DETECTION AND PREVENTION
    38. Alo, PL; Visca, P; Trombetta, G; Mangoni, A; Lenti, L; Monaco, S; Botti, C; Serpieri, DE; Di Tondo, U
      Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas

      TUMORI
    39. Gurel, S; Dolar, E; Yerci, O; Samli, B; Ozturk, H; Nak, SG; Gulten, M; Memik, F
      The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    40. Zeng, ZW; Melamed, J; Symmans, PJ; Cangiarella, JF; Shapiro, RL; Peralta, H; Symmans, WF
      Benign proliferative nipple duct lesions frequently contain CAM 5.2 and anti-cytokeratin 7 immunoreactive cells in the overlying epidermis

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    41. Ravdin, PM
      Should HER2 status be routinely measured for all breast cancer patients?

      SEMINARS IN ONCOLOGY
    42. Rabczynski, JK; Kochman, AT
      Primary cancer of the fallopian tube with transitional differentiation - Clinical and pathological assessment of 6 cases

      NEOPLASMA
    43. Takata, M; Fujimoto, A; Aoki, H; Hatta, N; Ooi, A; Takehara, K
      erbB-2 overexpression but no activation of beta-catenin gene in extramammary Paget's disease

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    44. Ross, JS; Fletcher, JA
      HER-2/neu (c-erb-B2) gene and protein in breast cancer

      AJCP. American journal of clinical pathology
    45. Wick, MR; Sayadi, H; Ritter, JH; Hill, DA; Reddy, VB; Gattuso, P
      Low-stage carcinoma of the male breast - A histologic, immunohistochemical, and flow cytometric comparison with localized female breast carcinoma

      AJCP. American journal of clinical pathology
    46. FLEISHER M
      PROGNOSTIC MARKERS OTHER THAN HORMONE RECEPTORS IN BREAST-CANCER

      Journal of clinical ligand assay
    47. SHACKNEY SE; POLLICE AA; SMITH CA; JANOCKO LE; SWEENEY L; BROWN KA; SINGH SG; GU LP; YAKULIS R; LUCKE JF
      INTRACELLULAR COEXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR, HER-2NEU, AND P21(RAS) IN HUMAN BREAST CANCERS - EVIDENCE FOR THE EXISTENCE OF DISTINCTIVE PATTERNS OF GENETIC EVOLUTION THAT ARE COMMON TO TUMORS FROM DIFFERENT PATIENTS/

      Clinical cancer research
    48. SHACKNEY SE; POLLICE AA; SMITH CA; JANOCKO LE; SWEENEY L; BROWN KA; SINGH SG; GU LP; YAKULIS R; LUCKE JF
      INTRACELLULAR COEXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR, HER-2NEU, AND P21(RAS) IN HUMAN BREAST CANCERS - EVIDENCE FOR THE EXISTENCE OF DISTINCTIVE PATTERNS OF GENETIC EVOLUTION THAT ARE COMMON TO TUMORS FROM DIFFERENT PATIENTS/

      Clinical cancer research
    49. ROSS JS; FLETCHER JA
      THE HER-2 NEU ONCOGENE IN BREAST-CANCER - PROGNOSTIC FACTOR, PREDICTIVE FACTOR, AND TARGET FOR THERAPY/

      Stem cells
    50. WILKMAN TSE; HIETANEN JPH; MALMSTROM MJ; KONTTINEN YT
      IMMUNOHISTOCHEMICAL ANALYSIS OF THE ONCOPROTEIN C-ERBB-2 EXPRESSION IN ORAL BENIGN AND MALIGNANT LESIONS

      International journal of oral and maxillofacial surgery
    51. ALLRED DC; HARVEY JM; BERARDO M; CLARK GM
      PROGNOSTIC AND PREDICTIVE FACTORS IN BREAST-CANCER BY IMMUNOHISTOCHEMICAL ANALYSIS

      Modern pathology
    52. VONBOSSANYI P; SALLABA J; DIETZMANN K; WARICHKIRCHES M; KIRCHES E
      CORRELATION OF TGF-ALPHA AND EGF-RECEPTOR EXPRESSION WITH PROLIFERATIVE ACTIVITY IN HUMAN ASTROCYTIC GLIOMAS

      Pathology research and practice
    53. Kim, YT; Kim, JW; Lee, JW
      c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors

      CANCER LETTERS
    54. OROURKE DM; GREENE MI
      IMMUNOLOGICAL APPROACHES TO INHIBITING CELL-SURFACE-RESIDING ONCOPROTEINS IN HUMAN TUMORS

      Immunologic research
    55. Henderson, IC; Patek, AJ
      The relationship between prognostic and predictive factors in the management of breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    56. VERMEULEN C; BOUGEROL O; SIBLANI Y
      PERIANAL PAGETS-DISEASE - REPORT OF A CAS E AND REVIEW OF THE LITERATURE

      La Semaine des hopitaux de Paris
    57. SUZUKI M; ICHIMIYA I; MATSUSHITA F; MOGI G
      HISTOLOGICAL FEATURES AND PROGNOSIS OF PATIENTS WITH MUCOEPIDERMOID CARCINOMA OF THE PAROTID-GLAND

      Journal of Laryngology and Otology
    58. YAN DH
      TARGETING HUMAN BREAST-CANCER CELLS THAT OVEREXPRESS HER-2 NEU MESSENGER-RNA BY AN ANTISENSE IRON-RESPONSIVE ELEMENT/

      Biochemical and biophysical research communications
    59. OROURKE DM; ZHANG X; GREENE MI
      PRINCIPLES OF RECEPTOR-BASED INHIBITION OF ERBB FAMILY RECEPTOR KINASES - PROSPECTS FOR NEW THERAPIES FOR HUMAN CANCERS

      Proceedings of the Association of American Physicians
    60. MARTINEZBARBA E; CORTESGUARDIOLA JA; MINGUELAPURAS A; TORROBACARON A; MENDEZTRUJILLO S; BERMEJOLOPEZ J
      SALIVARY DUCT CARCINOMA - CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICALSTUDIES

      Journal of cranio-maxillo-facial surgery
    61. BATES NP; HURST HC
      AN INTRON-1 ENHANCER ELEMENT MEDIATES ESTROGEN-INDUCED SUPPRESSION OFERBB2 EXPRESSION

      Oncogene
    62. WILLSHER PC; LEACH LH; ELLIS IO; BELL JA; ELSTON CW; BOURKE JB; BLAMEY RW; ROBERTSON JFR
      MALE BREAST-CANCER - PATHOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES

      Anticancer research
    63. BRANDTRAUF PW
      BIOMARKERS OF GENE-EXPRESSION - GROWTH-FACTORS AND ONCOPROTEINS

      Environmental health perspectives
    64. IMAMURA Y; ISHIDA M; HORITA K; FUKUDA M
      PROGNOSTIC FACTORS AND PROLIFERATIVE ACTIVITIES IN BREAST-CANCER - A COMPARATIVE-STUDY BETWEEN RECURRENT AND NONRECURRENT CASES OF HUMAN BREAST CARCINOMAS

      Acta histochemica et cytochemica
    65. KRAINER M; BRODOWICZ T; ZEILLINGER R; WILTSCHKE C; SCHOLTEN C; SEIFERT M; KUBISTA E; ZIELINSKI CC
      TISSUE EXPRESSION AND SERUM LEVELS OF HER-2 NEU IN PATIENTS WITH BREAST-CANCER/

      Oncology
    66. COWAN WK; KELLY P; SAWAN A; CUNLIFFE WJ; HENRY L; HIGGS MJ; LUNT LG; YOUNG JR; HORNE CHW; ANGUS B
      THE PATHOLOGICAL AND BIOLOGICAL NATURE OF SCREEN-DETECTED BREAST CARCINOMAS - A MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY

      Journal of pathology
    67. KOUKOURAKIS MI; GIATROMANOLAKI A; OBYRNE KJ; WHITEHOUSE RM; TALBOT DC; GATTER KC; HARRIS AL
      POTENTIAL ROLE OF BCL-2 AS A SUPPRESSOR OF TUMOR ANGIOGENESIS IN NON-SMALL-CELL LUNG-CANCER

      International journal of cancer
    68. KIMMIG R; PFEIFFER D; LANDSMANN H; HEPP H
      QUANTITATIVE-DETERMINATION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR INCERVICAL-CANCER AND NORMAL CERVICAL EPITHELIUM BY 2-COLOR FLOW-CYTOMETRY - EVIDENCE FOR DOWN-REGULATION IN CERVICAL-CANCER

      International journal of cancer
    69. BRODOWICZ T; WILTSCHKE C; BUDINSKY AC; KRAINER M; STEGER GG; ZIELINSKI CC
      SOLUBLE HER-2 NEU NEUTRALIZES BIOLOGIC EFFECTS OF ANTI-HER-2/NEU ANTIBODY ON BREAST-CANCER CELLS IN-VITRO/

      International journal of cancer
    70. NAKANO T; OKA K; ISHIKAWA A; MORITA S
      CORRELATION OF CERVICAL-CARCINOMA C-ERB B-2 ONCOGENE WITH CELL-PROLIFERATION PARAMETERS IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CERVICAL-CARCINOMA

      Cancer
    71. AHMED NU; UEDA M; ICHIHASHI M
      INCREASED LEVEL OF C-ERBB-2 NEU/HER-2 PROTEIN IN CUTANEOUS SQUAMOUS-CELL CARCINOMA/

      British journal of dermatology
    72. TAKATA M; HATTA N; TAKEHARA K
      TUMOR-CELLS OF EXTRAMAMMARY PAGETS-DISEASE DO NOT SHOW EITHER P53 MUTATION OR ALLELIC LOSS AT SEVERAL SELECTED LOCI IMPLICATED IN OTHER CANCERS

      British Journal of Cancer
    73. BROTHERICK I; SHENTON BK; EGAN M; CUNLIFFE WE; BROWELL DA; LUNT LG; YOUNG JR; HIGGS MJ
      EXAMINATION OF MULTIDRUG-RESISTANCE IN CELL-LINES AND PRIMARY BREAST-TUMORS BY FLOW-CYTOMETRY

      European journal of cancer
    74. WARRI AM; ISOLA JJ; HARKONEN PL
      ANTIESTROGEN STIMULATION OF ERBB2 ECTODOMAIN SHEDDING FROM BT-474 HUMAN BREAST-CANCER CELLS WITH ERBB2 GENE AMPLIFICATION

      European journal of cancer
    75. RAMACHANDRA S; GILLETT CE; MILLIS RR
      A COMPARATIVE IMMUNOHISTOCHEMICAL STUDY OF MAMMARY AND EXTRAMAMMARY PAGETS-DISEASE AND SUPERFICIAL SPREADING MELANOMA, WITH PARTICULAR EMPHASIS ON MELANOCYTIC MARKERS

      Virchows Archiv
    76. CANEVARI S; PUPA SM; MENARD S
      1975-1995 REVISED ANTICANCER SEROLOGICAL RESPONSE - BIOLOGICAL SIGNIFICANCE AND CLINICAL IMPLICATIONS

      Annals of oncology
    77. BRUCE DM; HEYS SD; PAYNE S; MILLER ID; EREMIN O
      MALE BREAST-CANCER - CLINICOPATHOLOGICAL FEATURES, IMMUNOCYTOCHEMICALCHARACTERISTICS AND PROGNOSIS

      European journal of surgical oncology
    78. BAST RC; BATES S; BREDT AB; DESCH CE; FRITSCHE H; FUES L; HAYES DF; KEMENY NE; KRAGEN M; JESSUP J; LOCKER GY; MACDONALD JS; MENNEL RG; NORTON L; RAVDIN P; SMITH TJ; TAUBE S; WINN RJ
      CLINICAL-PRACTICE GUIDELINES FOR THE USE OF TUMOR-MARKERS IN BREAST AND COLORECTAL-CANCER

      Journal of clinical oncology
    79. KURZL RG
      PAGETS-DISEASE

      Seminars in dermatology
    80. IOACHIM E; KAMINA S; ATHANASSIADOU S; AGNANTIS NJ
      THE PROGNOSTIC-SIGNIFICANCE OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR), C-ERBB-2, KI-67 AND PCNA EXPRESSION IN BREAST-CANCER

      Anticancer research
    81. VOGEL W; KATH R; KOSMEHL H; OLSCHOWSKY E
      THE NEU ONCOGENE PRODUCT IN SERUM AND TISSUE OF PATIENTS WITH METASTATIC GASTROINTESTINAL CARCINOMAS

      Journal of cancer research and clinical oncology
    82. PIFFANELLI A; DITTADI R; CATOZZI L; GION M; CAPITANIO G; GELLI MC; BRAZZALE A; MALAGUTTI R; PELIZZOLA D; MENEGON A; GIOVANNINI G; GARDINI G
      DETERMINATION OF ERBB2 PROTEIN IN BREAST-CANCER TISSUES BY DIFFERENT METHODS - RELATIONSHIPS WITH OTHER BIOLOGICAL PARAMETERS

      Breast cancer research and treatment
    83. JAMALI FR; RICCI A; DECKERS PJ
      PAGETS-DISEASE OF THE NIPPLE-AREOLA COMPLEX

      The Surgical clinics of North America
    84. MYERS RB; BROWN D; OELSCHLAGER DK; WATERBOR JW; MARSHALL ME; SRIVASTAVA S; STOCKARD CR; URBAN DA; GRIZZLE WE
      ELEVATED SERUM LEVELS OF P105(ERBB-2) IN PATIENTS WITH ADVANCED-STAGEPROSTATIC ADENOCARCINOMA

      International journal of cancer
    85. MANGILI F; SASSI I; DIROCCO M; LEONE BE; GARANCINI P; SANTAMBROGIO G
      BREAST-CARCINOMA DETECTION WITH A COMBINATION OF RADIOLABELED MONOCLONAL-ANTIBODIES - PROMISING RESULTS FROM IMMUNOHISTOCHEMISTRY STUDIES

      Cancer
    86. ALO PL; VISCA P; MARCI A; MANGONI A; BOTTI C; DITONDO U
      EXPRESSION OF FATTY-ACID SYNTHASE (FAS) AS A PREDICTOR OF RECURRENCE IN STAGE-I BREAST-CARCINOMA PATIENTS

      Cancer
    87. ONDA M; MATSUDA S; HIGAKI S; IIJIMA T; FUKUSHIMA J; YOKOKURA A; KOJIMA T; HORIUCHI H; KUROKAWA T; YAMAMOTO T
      ERBB-2 EXPRESSION IS CORRELATED WITH POOR-PROGNOSIS FOR PATIENTS WITHOSTEOSARCOMA

      Cancer
    88. ROBERTSON JFR
      ESTROGEN-RECEPTOR - A STABLE PHENOTYPE IN BREAST-CANCER

      British Journal of Cancer
    89. WEISSFELD JL; LARSEN RD; NIMAN HL; KULLER LH
      ONCOGENE-RELATED SERUM-PROTEINS AND CANCER RISK - A NESTED CASE-CONTROL STUDY

      American journal of epidemiology
    90. LEONG ASY; ROBBINS P; SPAGNOLO DV
      TUMOR GENES AND THEIR PROTEINS IN CYTOLOGIC AND SURGICAL SPECIMENS - RELEVANCE AND DETECTION SYSTEMS

      Diagnostic cytopathology
    91. BRANDTRAUF PW; DEVIVO I; MARION MJ; HEMMINKI K
      THE MOLECULAR EPIDEMIOLOGY OF GROWTH SIGNAL-TRANSDUCTION PROTEINS

      Journal of occupational and environmental medicine
    92. KACINSKI BM; NGUYEN J; CARTER D
      EXPRESSION OF NEU ANTIGEN IN NORMAL LACTATING AND PREPARTUM MAMMARY EPITHELIAL-CELLS

      Journal of the Society for Gynecologic Investigation
    93. LUPU R; CARDILLO M; HARRIS L; HIJAZI M; ROSENBERG K
      INTERACTION BETWEEN ERBB- RECEPTORS AND HEREGULIN IN BREAST-CANCER TUMOR PROGRESSION AND DRUG-RESISTANCE

      Seminars in cancer biology
    94. HAERSLEV T; JACOBSEN GK; ZEDELER K
      PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND C-ERBB-2 ONCOPROTEIN INBREAST-CARCINOMA WITH CORRELATIONS TO HISTOPATHOLOGICAL PARAMETERS AND PROGNOSIS

      Oncology Reports
    95. DEPOTTER CR; SCHELFHOUT AM
      THE NEU-PROTEIN AND BREAST-CANCER

      Virchows Archiv
    96. WEBB A; SCOTTMACKIE P; CUNNINGHAM D; NORMAN A; ANDREYEV J; OBRIEN M; BENSTED J
      THE PROGNOSTIC VALUE OF CEA, BETA-HCG, AFP, CA125, CA19-9 AND C-ERB B-2, BETA-HCG IMMUNOHISTOCHEMISTRY IN ADVANCED COLORECTAL-CANCER

      Annals of oncology
    97. CECCARELLI C; SANTINI D; CHIECO P; TAFFURELLI M; MARRANO D; MANCINI AM
      MULTIPLE EXPRESSION PATTERNS OF BIOPATHOLOGICAL MARKERS IN PRIMARY INVASIVE BREAST-CARCINOMA - A USEFUL TOOL FOR ELUCIDATING ITS BIOLOGICALBEHAVIOR

      Annals of oncology
    98. SUN XF; CARSTENSEN JM; STAL O; ZHANG H; NORDENSKJOLD B
      C-ERBB-2 ONCOPROTEIN IN RELATION TO DNA-PLOIDY AND PROGNOSIS IN COLORECTAL ADENOCARCINOMA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    99. GORGOULIS VG; BARBATIS C; POULIAS I; KARAMERIS AM
      MOLECULAR AND IMMUNOHISTOCHEMICAL EVALUATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERB-B-2 GENE-PRODUCT IN TRANSITIONAL-CELL CARCINOMASOF THE URINARY-BLADDER - A STUDY IN GREEK PATIENTS

      Modern pathology
    100. EDORH A; PARACHE RM; MIGEON C; NSOSSANI B; RIHN B
      EXPRESSION OF C-ERBB-2 ONCOPROTEIN IN MAM MARY PAGETS-DISEASE - IMMUNOHISTOCHEMICAL STUDY BY USING 3 DIFFERENT ANTIBODIES

      Pathologie et biologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 14/08/20 alle ore 10:56:50